Process Chemistry: The science, business, logic, and logistics

Chemical Reviews

Volumn 106, Issue 7, 2006, Pages 2583-2595

  Zhang, Tony Y ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL INDUSTRY; CHEMICAL PLANTS; DRUG PRODUCTS PLANTS; ENVIRONMENTAL IMPACT; INDUSTRIAL PLANTS; SAFETY FACTOR;

MASS THROUGHPUT; PROCESS CHEMISTRY; PROCESS RESEARCH;

CHEMISTRY;

DRUG;

CHEMISTRY; DRUG DESIGN; ECONOMICS; LOGIC; METHODOLOGY; ORGANIZATION AND MANAGEMENT; REVIEW; SYNTHESIS;

CHEMISTRY, PHARMACEUTICAL; DRUG DESIGN; LOGIC; ORGANIZATION AND ADMINISTRATION; PHARMACEUTICAL PREPARATIONS;

EID: 33747041670     PISSN: 00092665     EISSN: None     Source Type: Journal    
DOI: 10.1021/cr040677v     Document Type: Review

References (70)

1. Hirai, K.; Uchida, A.; Ohno, R. Major synthetic routes for modern herbicide classes and agrochemical characteristics. In Herbicide Classes in Development: mode of action, targets, genetic engineering, chemistry; Böger, P., Wakabayashi, K., Hirai, K., Eds.; Springer-Verlag: Berlin, 2002.
2. New Chemistries for Crop Protection, Conference Proceedings of SCI Crop Protection and BioActive Sciences Groups; Copping, L., Dingwall, J., Eds.; John Wiley & Sons: Chichester, U.K., 2002.
3. Synthesis and Chemistry of Agrochemicals VI; Baker, D. R., Fenyes, J. G., Lahm, G. P., Selby, T. P., Stevenson, T. M., Eds.; ACS Symposium Series 800; American Chemical Society: Washington, DC, 2002.
4. Bauer, K.; Garbe, D.; Surburg, H. Common Fragrance and Flavor Materials: Preparation, Properties and Uses, 4th ed.; John Wiley & Sons: Chichester, U.K., 2001.
5. Chemistry and Technology of Flavors and Fragrances; Rowe, D. J., Ed.; CRC Press: Boca Raton, FL, 2005.
6. Proceedings of Flavors and Fragrances 2001: From the Sensation to the Synthesis; Swift, K. A., Ed.; Royal Society of Chemistry: Cambridge, U.K., 2002.
7. According to a recent ACS survey, pharmaceutical and related fields account for 21.6% of chemists employed full time (vs 12% in 1985). For details, see: Heylin, M. Chem. Eng. News 2005, 83 (31), 41-51. (http://pubs.acs.org/cen/acsnews/83/pdf/8331salary.pdf).
8. Chemistry and Biology of β-lactams Antibiotics; Morin, R. B., Gorman, M., Eds.; Academic Press: New York, 1982; Vols. I-III.
9. Laird, T. Chem. Br. 1989, 25, 1208-1211.
10. Laird, T. Development and scale-up of Process for the Manufacturing of New Pharmaceutical. In Comprehensive Medicinal Chemistry; Hansch, C., Sammes, P. G., Taylor, J. B., Drayton, C. J., Eds.; Pergamon Press: Oxford, U.K., 1990; Vol. 1, pp 321-359.
11. Cabri, W.; Di Fabio, R. From Bench to Market: The Evolution of Chemical Synthesis; Oxford University Press: New York, 2000.
12. Anderson, N. G. Practical Process Research and Development; Academic Press: San Diego, CA, 2000.
13. Process Development - from Grams to Kilos; Lee, S., Robinson, G. E., Eds.; Oxford Science: Oxford, U.K., 1995.
14. Repic, O. Principles of Process Research and Chemical Development in the Pharmaceutical Industry; John Wiley & Sons: New York, 1998.
15. Euzen, J.-P.; Trambouze, P.; Wauquier, J.-P. Scale-up Methodology for Chemical Processes; Technip: Paris, 1993.
16. Process Chemistry in the Pharmaceutical Industry; Gadamasetti, K. G., Ed.; Dekker: New York, 1999.
17. Atherton, J. H.; Carpenter, K. J. Process Development: Physico-chemical Concepts; Oxford University Press: Oxford, U.K., 1999.
18. Someswara Rao, C. The Chemistry of Process Development in Fine Chemical & Pharmaceutical Industry; Asian Books Private Limited: New Delhi, 2004.
19. Organometallics in Process Chemistry; Larsen, R. D., Ed. Springer: Berlin, 2004.
20. Blaser, H. U.; Schmidt E. Asymmetric Catalysis on an Industrial Scale; Wiley-VCH: New York, 2004.
21. Active Pharmaceutical Ingredients; Development Manufacturing and Regulation; Nusim, S. H., Ed.; Marcel Dekker: New York, 2005.
22. From Bench to Pilot Plant: Process Research in the Pharmaceutical Industry; Nafissi M., Ragan, J. A., DeVries, K. M., Eds.; ACS Symposium Series 817; American Chemical Society: Washington, DC, 2002.
23. Chemical Process Research: The Art of Practical Organic Synthesis; Abdel-Magid, A. F., Ragan, J. A., Eds.; ACS Symposium Series 870; American Chemical Society: Washington, DC, 2003.
24. For example, The Annual Society of Chemical Industry (SCI, U.K.) Process Research & Development Conference, Cambridge, U.K.;
25. Organic Process Research and Development Conferences by Scientific Updates (www.scientificupdate.co.uk)
26. Perspectives in Process Chemistry by American Chemical Society (www.chemistry.org);
27. and Midwest Pharmaceutical Process Chemistry Consortium (MPPCC) by major research-based pharmaceutical companies (www.mppcc.com);
28. the Annual International Conference on Process Chemistry and Technology, hosted by Rhodia Pharm Solutions; the Siegfried Symposium on New Methods in Process Chemistry, University of Zurich.
29. For the Organic Process Research & Development journal website, go to http://pubs.acs.org/journals/oprdfk/.
30. For a detailed explanation of the modern drug development process, see: The Process of New Drug Discovery and Development; Smith, C. G., Ed.; CRC Press: Boca Raton, FL, 1992. The website of the Pharmaceutical Research and Manufacturers of America (PhRMA) is also a useful resource for current development (http://www.phrma.org).
31. Pharmaceutical cGMPs for the 21st Century - A Risk-Based Approach; US FDA CDER report; Department of Health and Human Services, U.S. Food and Drug Administration: Rockville, MD, 2004 (http://www.fda.gov/cder/gmp/ gmp2004/GMP_finalreport2004.htm).
32. Q8 Pharmaceutical Development, A draft guidance for industry; U.S. Food and Drug Administration: Rockville, MD, 2005 (http://www.fda.gov/ohrms/ dockets/98fr/2005d-0021-gd1000.pdf).
33. Q7A Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients, Guidance for industry; U.S. Food and Drug Administration: Rockville, MD, 2001 (http://www.fda.gov/cder/guidance/4286fnl.htm).
34. See also content at http://apic.cefic.org/pub/IGMP-API9604.pdf.
35. Pisano, G. The Development Factory; Harvard Business School Press: Cambridge, MA, 1997.
36. Anderson, N. G. Org. Process Res. Dev. 2004, 8, 260.
37. Regulatory starting materials refers to the raw materials or intermediates for the production of drug substances designated as starting materials according to guidelines provided by the U.S. Food and Drug Administration. They signify the start of the manufacturing process regulated by GMPs (good manufacturing practices). For details, see http://www.fda.gov/cder/guidance, http://www.fda.gov/cder/guidance, and http://www.fda.gov/cder/guidance/1289dft.pdf.
38. Hudlicky, T. Chem. Rev. 1996, 96, 3.
39. Warren, S. Organic Synthesis: the disconnection approach; Wiley: Chichester, U.K., 1992.
40. Wender, P. A.; Handy, S. T.; Wright, D. L. Chem. Ind. 1997, 765, 767.
41. For a series of recent articles on safety of chemical processes, see: Org. Process Res. Dev. 2002, 6, 876-942; 2005, 9, 951-1012.
42. Chemical Reaction Hazards, 2nd ed.; Barton, J., Rogers, R., Eds.; Institute of Chemical Engineers: Rugby, U.K., 1996.
43. Skelton R. Process Safety Analysis, An Introduction; Institute of Chemical Engineers: Rugby, U.K., 1997.
44. Marshall, V.; Ruhemann, S. Fundamental Process Safety; Institute of Chemical Engineers: Rugby, U.K., 2001.
45. Hazard Study and Risk Assessment in the Pharmaceutical Industry; Gillett, J. E., Ed; Interpharm Press: Buffalo Grove, IL, 1997.
46. Steinbach, J. Safety Assessment for Chemical Processes; Wiley: New York, 1999.
47. Prevention of Fires and Explosions in Dryers. A User Guide, 2nd ed.; Abbott, J. A., Ed.; Institution of Chemical Engineers: Rugby, U.K., 1990.
48. Zhang, T. Y. Waste minimization in pharmaceutical process development: principles, practice and challenges. In Handbook of Green Chemistry and Technology; Clark, J., Macquarrie, D., Eds.; Blackwell Science Ltd: Oxford, U.K., 2002.
49. Kohlman, T. D.; Xu, Y.; Godfrey, A. G.; O'Toole, J. C.; Zhang, T. Y. European Patent EP924205, 1999.
50. Anastas, P.; Warner, J. Green Chemistry: Theory and Practice; Oxford University Press: Oxford, U.K. 1998.
51. Trost, B. M. Science 1991, 254, 1471.
52. Sheldon, R. A. CHEMTECH 1994, 24, 38-47.
53. Sheldon, R. A. C. R. Acad. Sci., Ser. IIc: Chim. 2000, 3, 541-551.
54. Sheldon, R. A. Green Chem. 2005, 7, 267 and references therein.
55. Carlson, R. Design and Optimization in Organic Synthesis, 2nd ed.; Elsevier: New York, 2005.
56. Gooding, O. W. Curr. Opin. Chem. Biol. 2004, 8, 297.
57. For US FDA's Process Analytical Technology (PAT) Initiative, see http://www.fda.gov/cder/OPS/PAT.htm.
58. Brereton, R. G. PAT - J. Process Anal. Technol. 2005, 2, 8.
59. Hinz, D. C. PAT - J. Process Anal. Technol. 2004, 1, 16.
60. Yu, L. X.; Lionberger, R. A.; Raw, A. S.; D'Costa, R.; Wu, H.; Hussain, A. S. Adv. Drug Delivery Rev. 2004, 56, 349.
61. Mullin, J. W. Crystallization, 4th ed.; Butterworth-Heinemann: Oxford, U.K., 2001.
62. Laird, T. Org. Process Res. Dev. 2004, 8, 301.
63. For a series of special issues on polymorphism and crystallization process development, see: Org. Process Res. Dev., 2000, 4, 370-371; 2003, 7, 957-1027; 2005, 9, 857-942.
64. Myerson, A. Crystal Growth of Organic Materials; American Chemical Society: Washington, DC, 1996.
65. Corey, E. J.; Cheng, X. The Logic of Chemical Synthesis; John Wiley & Sons: New York, 1989.
66. Hendrickson, J. B. Acc. Chem. Res. 1986, 19, 274-281.
67. Classics in Total Synthesis; Nicolaou, K. C., Sorensen, E., Eds.; VCH: Weinheim, Germany, 1995.
68. Classics in Total Synthesis II: Targets, Strategies, Methods; Nicolaou, K. C., Snyder, A., Eds.; John Wiley & Sons: Chichester, U.K., 2003.
69. Key assumptions: Eight step linear synthesis as shown in Figure 2. Each step is 90% in yield except as noted. Each substrate fragment (A, B,..., I) has a molecular weight of 50 and a cost of $300/kg; all steps were run at 10 volume concentration [L(solvent)/kg(total weight of substrates)] except as noted. Solvent charge is $2/L. Conversion cost is assigned as a function of reaction volume to reflect its dependence on throughput.
70. For an excellent attempt at objectively quantifying synthetic efficiencies using intricacy quotient (IQ), see Fuchs, P. L. Tetrahedron, 2001, 57, 6855.